Fullerenes: From carbon to nanomedicine

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 8, 2010, Pages 662-677

  Chawla, Pooja ^a   Chawla, Viney ^b   Maheshwari, Radhika ^a   Saraf, Shubhini A ^a   Saraf, Shailendra K ^b  

^a BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

^b Northern India Engineering College   (India)

Author keywords

Anti HIV; Antiapoptotic; Antioxidant; Enzyme inhibition; Nanomedicines; Neuroprotective

Indexed keywords

CARBON NANOTUBE; FULLERENE; MONOCLONAL ANTIBODY; NANOWIRE; PROTEINASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARBON; ENZYME INHIBITOR; FULLERENE DERIVATIVE; NEUROPROTECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CARDIOVASCULAR EFFECT; CATALYSIS; DRUG DELIVERY SYSTEM; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; LIVER PROTECTION; NANOMEDICINE; NEUROPROTECTION; NONHUMAN; POLYMERIZATION; SOLUBILITY; STRUCTURE ACTIVITY RELATION; SUPERCONDUCTOR; CHEMISTRY;

ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CARBON; ENZYME INHIBITORS; FULLERENES; NANOMEDICINE; NEUROPROTECTIVE AGENTS;

EID: 77954726292     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955710791572497     Document Type: Article

References (146)

1. 60 - Buckminsterfullerene. Chem. Rev., 1991, 91, 1213-1235.
2. 60-Buckminsterfullerene. Nature, 1985, 318, 162-163.
3. st ed.; Pearson Education: Singapore, 2005.
4. 70: the third form of carbon. J. Chem. Soc. Chem. Commun., 1990, 20, 1423-1425.
5. 60 by light. Nature, 1991, 351, 277.
6. 60 with Oxygen Induced by Photoexcitation. Chem. Lett., 1992, 21, 1659-1662.
7. 60. A new inexpensive and facile method. J. Am. Chem. Soc., 1992, 114, 7917-7919.
8. 70 on titanium dioxide particles. J. Chem. Soc. Chem. Commun., 1992, 19, 1470-1471.
9. 60) in pure oxygen, nitrogen and argon. J. Phys. Chem, 1992, 96, 1016-1018.
10. 60-Ih)[5,6]fullerene. Org. Syntheses, 2006, 83, 80-81.
11. Nakamura, Y.; Suzuki, M.; Imai, Y.; Nishimura, J. Synthesis of [60]Fullerene Adducts Bearing Carbazole Moieties by Bingel Reaction and Their Properties. Org. Lett., 2004, 6, 2797-2799.
12. Iwashita, A; Matsuo, Y.; Nakamura, E. AlCl3 mediated mono-, di- and trihydroarylation of C(60) Fullerene. Angew. Chem. Int. Ed., 2007, 46, 3513-3516.
13. 60: Synthesis, characterization, and functionalization of fullerene pyrrolidines. J. Am. Chem. Soc., 1993, 115, 9798-9799.
14. 8. Nature, 1992, 357, 479-481.
15. 24) and Stearic acid mixed Langmuir films at air water interface. Chem. Phys. Lett., 2007, 433, 317-322.
16. 6048 with improved yield and selectivity. J. Fluorine Chem., 2006, 127, 832-836.
17. 60F60. J. Am. Chem. Soc., 2008, 130, 3985-3988.
18. Manolis, M.; Roubelakis, G.; Vougioukalakis, C.; Orfanopoulos, M. Open-Cage Fullerene Derivatives Having 11-, 12-, and 13-Membered-Ring Orifices: Chemical Transformations of the Organic Addends on the Rim of the Orifice. J. Org. Chem., 2007, 72, 6526-6533.
19. Hummelen, J.C.; Prato, M.; Wudl, F. There Is a Hole in My Bucky. J. Am. Chem. Soc., 1995, 117, 7003-7004.
20. Taylor, R.; Walton, D.R.M. The chemistry of fullerenes. Nature, 1993, 363, 685-693.
21. Taylor, R. The chemistry of fullerenes; World Scientific: Singapore 1995.
22. 60 in organic solvents. J. Org. Chem., 1992, 57, 6077-6079.
23. 60) in a variety of solvents. J. Phys. Chem., 1993, 97, 3379-3383.
24. 28 (M=Mg, Al, Si, S, Ca, Sc, Ti, Ge. http/adsabs.harvard.edu/ads/1993JPhCh.99.352G.
25. Da Ros, T.; Prato, M. Medicinal chemistry with fullerenes and fullerene derivatives. Chem. Commun., 1999, 663-669.
26. 60. Nature, 1991, 350, 600-601.
27. Saunders, M.; Jimenz-Vazquez, H.A.; Cross, R.J.; Mroczkoneski, S.; Gilbin, E.D.; Poreda, R.J. Incorporation of helium, neon, argon, krypton and xenon into fullerenes using high pressure. J. Am. Chem. Soc., 1994, 116, 2193-2194.
28. 82. J. Phys. Chem. A., 2008, 112, 1294-1297.
29. 60: The Influence of the Addition Pattern and the Addend. Chem. Eur. J., 1996, 2, 935-943.
30. 58X (X=S, Se, Te): A DFT study Chem. Phys. Lett., 2009, 47, 116-121.
31. 14C labeling, absorption, distribution, excretion and acute toxicity. Chem. Biol., 1995, 2, 385-389.
32. Tagmatarchis, N.; Shinohara H. Fullerenes in Medicinal Chemistry and their Biological Applications. Mini Rev. Med. Chem., 2001, 1, 339-348.
33. Wilson, S. R. In: The fullerene Handbook, K Kadish, Ruoff (Ed.), Wiley, New York, 2000, 437-465.
34. Jeusen, W.; Wilson, S.R.; Schuster, D.I. Biological applications of fullerenes. Bioorg. Med. Chem., 1996, 4, 767-779.
35. Dugan, L.; Gabrielesen, J.; Yu, S.; Lin, T.; Choi, D.: Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis., 1996, 3, 129-135.
36. 60HyFn) protect rat brain against alcohol impact and attenuate behavioral impairments of alcoholized animals. Toxicology, 2008, 246, 158-165.
37. Lin, A.H.U.; Fang, S.; Lin, S.; Chou, C.; Luh, T.; Ho, L. Local carboxyfullerene protects cortical infarction in rat brain, Neurosci. Res., 2002, 43, 317-321.
38. Dugan, L.; Lovett, E.; Quick, K.; Lotharius, J.; Lin, T.; O'Malley, K. Fullerene based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord., 2001, 7, 243-246.
39. Dugan, L.; Turetsky, D.; Du, C.; Lobner, D.; Wheeler, M.; Almli, R.; Shen, C.K.F.; Luh, T.; Choi, D.; Lin, T. Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. USA, 1997, 94, 9434-9439.
40. Huang, Y.; Shen, C.; Luh, T.; Yang, H.; Hwang, K.; Chou, C. Blockage of apoptotic signalling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene. Eur. J. Biochem., 1998, 254, 38-43.
41. 60, fullerenol, a novel free radical trapper Prevented hydrogen peroxide and cumene hydroperoxide-elicited changes in rat hippocampus in vitro. J. Pharm. Pharmacol., 1997, 49, 438-445.
42. 60 fullerene on amyloid peptide fibrillization in vitro and performance of the cognitive task. J. Nanosci. Nanotechnol., 2007, 7, 1479-1485.
43. Kim, J.E.; Lee, M. Fullerenes inhibit β-amyloid peptide aggregation. Biochem. Biophys. Res. Commu., 2003, 303, 576-579.
44. Lai, H.S.; Chen, W.J.; Chiang, L.Y. Free Radical Scavenging Activity of Fullerenol on the Ischemia-reperfusion Intestine in Dogs. World J. Surgery, 2000, 24, 450-454.
45. Bisaglia, M.; Nataleni, B.; Pelluari, R.; Straface, E.; Manlorni, W.; Monti, D. C3-Fullero-tris- Methanodicarboxylic Acid Protects Cerebellar Granule Cells from Apoptosis. J. Neurochem., 2000, 74, 1197-1204.
46. Cheuh, S.C.; Lai, M.K.; Lee, M.S.; Chiang, L.Y.; Ho, Ti; Chen, S.C. Decrease of free radical level in organ perfusate by a novel water soluble carbon sixty hexa (sulfobutyl) fullerenes. Transplantation Proceedings, 1999, 31, 1976-1977.
47. www.csixty.com/antioxidant.html/1/7/2004.
48. Lai, Y. L.; Murugan, P.; Hwang, K.C. Fullerene derivative attenuates ischemia-reperfusion induced lung injury. Life Sci., 2003, 72, 1271-1278.
49. 2 in the mechanism that underlies the combined effects of methamphetamine and morphine on subacute toxicity or lethality in mice: Comparison of the therapeutic potential of fullerene, mepacrine and cooling, Toxicology, 2007, 236, 149-157.
50. 60 and Water Soluble Fullerene Derivatives as Antioxidants Against Radical Initiated Lipid Peroxidation J. Med. Chem., 1999, 42, 4614-4620.
51. Halliwell, B. Reactive Oxygen Species and the Central Nervous System. J. Neurochem., 1992, 59, 1609-1623.
52. 60 fullerene. Antimicrob. Agents Chemother., 1993, 37, 1707-1710.
53. Rubin, Y. In The Chemical Physics of Fullerenes 10 (and 5) Years Later, Andreoni, W. Ed., Kluwer Academic Publishers, Dordrecht, 1996; pp. 295-328.
54. Friedman, S.H.; Decamp, D.L.; Sijbesma, R.P.; Srdanov, G.; Wadr, F.; Kenyon, G.L. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J. Am. Chem. Soc., 1993, 115, 6506-6509.
55. Mashino, T.; Shimotohno, K.; Ikegami, N.; Nishikawa, D.; Okuda, K.; Takahashi, K.; Nakamura, S.; Mochizuki, M. Human immunodeficiency virus reverse transcriptase inhibition and hepatitis C virus RNA dependant RNA polymerase inhibition activities of fullerene derivatives. Bioorg. Med. Chem. Lett., 2005, 15, 1107-1109.
56. Tokuyama, H.; Yamgo, S.; Nakamura, E.; Shikari, T.; Sugiura, Y. Photo induced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc., 1993, 115, 7918-7919.
57. 60, a fullerene, on the Activities of Glutathione S-Transferase and Glutathioone-Related Enzymes in Rodent and Human Livers Fullerene Sci. Technol., 1998, 6, 213-226.
58. 60. Toxicol. Lett., 1997, 93, 29-37.
59. 60-Fullerene Adducts Arch. Biochem. Biophys., 2000, 378, 216-223.
60. Durdagi, S.; Mavromoustakos, T.; Papadopoulos, M.G. 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene based HIV-1 PR inhibitors. Bioorg. Med. Chem. Lett., 2008, 18, 6283-6289.
61. 60. J. Org. Chem., 1996, 61, 9070-9072.
62. Mashino, T.; Okuda, K.; Hirota, T.; Hirobe, M.; Nagano, T.; Mochizuchi, M. Inhibition of E. coli growth by fullerene derivatives and inhibition mechanism. Bioorg. Med. Chem. Lett., 1999, 9, 2959-2962.
63. Tsao, N.; Luh, T.Y.; Chau, C.K.; Wu, J.J.; Lin, Y.S.; Lei, H.Y. Inhibition of Group A Streptococcus Infection by Carboxyfullerene. Antimicrob. Agents Chemother., 2001, 45, 1788-1793.
64. Da Ros, T.; Spalluto, G.; Prato, M. Biological Applications of Fullerene Derivatives: A Brief Overview. Croatio Chemica Acta, 2001, 74, 743-755.
65. Bianco, A.; Da Ros, T.; Prato, M.; Toniolo, C. Fullerene-based amino acids and peptides. J. Pept. Sci., 2001, 7, 208-219.
66. Pellarini, F.; Pantarotto, D.; Da Ros, T.; Grangaspero, A.; Tassi, A.; Prato, M. A Novel (60) Fullerene Amino Acid for Use in Solid Phase Synthesis. Org. Lett., 2001, 3, 1845-1848.
67. Mashino, T.; Usui, N.; Okuda, K.; Hirota, T.; Mochizuki, M. Discovery of a nuclease-resistant dinucleotide that inhibits HIV-1 Integrase. Bioorg. Med. Chem. Lett., 2003, 11, 1433-1438.
68. Huang, Y.L.; Shen, C.K.; Luh, T.Y.; Yang, K.C.; Hwang C.K. Blockage of apoptotic signaling of transforming growth factor-β in human hepatoma cells by carboxyfullerene. Eur. J. Biochem., 1998, 254, 33-43.
69. Chien, C.; Lee, P.; Chen, C.; Ma, M.; Lai, M.; Hsu, S. De Novo Demonstration and Co-localisation of Free-Radical Production and Apoptosis Formation in Rat Kidney Subjected to Ischemia/Reperfusion. J. Am. Soc. Nephrol., 2001, 12, 973-982.
70. Hsu, S.C.; Wu, C.C.; Luh, T.Y.; Chou, C.K.; Han, S.H.; Lai, M.Z. Apoptotic Signal of Fas Is Not Mediated by Ceramide. Blood, 1998, 91, 2658-2663.
71. 60-linked deoxyoligonucleotide: Evidence for a non-singlet oxygen mechanism. Tetrahedron, 1996, 52, 5179-5189.
72. Friedman, S.H.; Ganapati, P.S.; Rubin, Y.; Kenyon, G.L. Optimizing the Binding of Fullerene Inhibitors of the HIV-1 Protease through Predicted increase in Hydrophobic Desolvation. J. Med. Chem., 1998, 41, 2424-2429.
73. 2. J. Am. Chem. Soc., 2003, 125, 12803-12809.
74. 60. J. Org. Chem., 1995, 60, 5372-5373.
75. 60 with aromatic hydrocarbons. Spectrochim Acta A., 1997, 53, 679-684.
76. Tokuyama, H.; Yamago, S.; Nakamura, E.; Shiraki, T.; Sugiura, Y. Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc., 1993, 115, 7918-7919.
77. Boutorine, A.S.; Takasugi, H.; Isobe, H.; Nakamura, E.; Helene, C. Fullerene-Oligonucleotide Conjugates: Photoinduced Sequence Specific DNA Cleavage. Angew. Chem. Int. Ed. Engl., 1994, 33, 2462-2465.
78. 60-NVP copolymer: a potential material for photodynamic therapy. Chem. Commun., 2006, 46, 4805-4807.
79. 60 derivatives containing biologically active 4-aryl-1,4-dihydropyridines Tetrahedron Lett., 2002, 43, 4133-4136.
80. Vogelson, C.T. Innovative pharmaceutical treatments require innovative methods of administration. Modern Drug Discov., 2001, 4, 49-52.
81. 3+ ions for photodynamic therapy. J. Control. Release, 2007, 117, 104-110.
82. Mroz, P.; Pawlak, A.; Satti, M.; Lee, H.; Wharton, T.; Gali, H.; Sarna, T.; Hamblin, M.R. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic. Biol. Med., 2007, 43, 711-719.
83. 60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials, 2009, 30, 1184-1196.
84. th ed. Kadish, K.M.; Rouff, R.S. Eds., The Electrochemical Society, Pennington, NJ, 2000, p. 258.
85. Wilson, L.J. Medical applications of fullerenes and metallofullerenes. Electrochem. Soc. Interface, 1999, 8, 24-28.
86. Thrash T.P.; Cagle D.W.; Alford, J.M.; Wright, K.; Ehrhardt, G.J.; Mirzadeh, S.; Wilson, L.J. Toward Fullerene-Based Radiopharmaceuticals: High-Yield Neutron Activation of Endohedral 165Ho Metallofullerenes. Chem. Phys. Lett., 1999, 308, 329-336.
87. Ehrhardt, G.J.; Wilson, L.J. In Nuclear and Radiation Chemical Approaches to Fullerene Science, Braun, T. Ed. Kluwer Academic Publishers: Netherlands, 2000; pp 174.
88. Mashino, T.; Usui, N.; Okuda, K.; Hirota, T.; Mochizuki, M. Respiratory chain inhibition by fullerene derivatives: hydrogen peroxide production caused by fullerene derivatives and a respiratory chain system. Bioorg. Med. Chem., 2003, 11, 1433-1438.
89. Willson, T.M.; Charifson, P.S.; Baxter, A.D.; Geddie, N.G. Bone targeted drugs 1. Identification of heterocycles with hydroxyapatite affinity. Bioorg. Med. Chem. Lett, 1996, 6, 1043-1046.
90. 16AMBP to mineralized bone. Bioorg. Med. Chem., 2002, 10, 1991-1997.
91. Chen, B.X.; Wilson, S.R.; Das, M.; Coughlin, D.J.; Erlanger, B.F. Antigenicity of fullerenes: Antibodies specific for fullerenes and their characteristics. Proc Natl. Acad. Sci. USA., 1998, 95, 10809-10813.
92. Loeser, R.F.; Carlson, C.S.; Del Carlo, M.; Cole, A. Detection of nitrotyrosine in ageing and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin- 1 and with chondrocyte resistance to insulin like growth factor. Arthritis Rheum., 2002, 46, 2349-2357.
93. Del Carlo, M.J.R.; Loeser, R.F. Nitric oxide mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum., 2002, 46, 391-403.
94. Yudoh, K.; Nakamura, H.; Masuko-Hongo, K.; Kato, T.; Nashioka, K. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1α in articular chondrocytes: involvement of HIF-1α in the pathogenesis of osteoarthritis. Arthritis Res. Ther., 2005, 7, R904-914.
95. Kurz, B.; Lemke, A.; Kehn, M.; Domm, C.; Patwari, P.; Frank, E.H. Influence of tissue maturation and antioxidants on the apoptotic response of articular cartilage after injurious compression. Arthritis Rheum., 2004, 50, 123-130.
96. Kurz, B.; Lemke, A.; Fay, J.; Pufe, T.; Grodzinsky, A.J.; Schunke, M. Pathomechanisms of cartilage destruction by mechanical injury. Ann. Anat., 2005, 187, 473-485.
97. 60. Science, 1991, 254, 1183-1185.
98. 60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem. Biophys. Res. Commun., 1995, 206, 885-894.
99. 60 intercalated graphite films. e-J Surf. Sci. Nanotech., 2005, 3, 21-23.
100. 60 molecular bearings. Phys. Rev. Lett. 2003, 90, 055509-055512.
101. Hunter, D.J.; Zhang, Y.; Niu, J.; Tu, X.; Amin, S.; Goggins, J. et al. Structural factors associated with malalignment in knee osteoarthritis: the Boston osteoarthritis knee study. J. Rheumatol., 2005, 32, 2192-2199.
102. Allen, T.M.; Cultis,P.R. Drug delivery systems: entering the mainstream. Science, 2004, 303, 1818-1822.
103. Kostarelos, K. Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science. Adv. Colloid Interface Sci., 2003, 106, 147-168.
104. Pantarotto, D.; Briand, J.P.; Prato, M.; Bianco, A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. (Camb.), 2004, 1, 16-17.
105. Shikam, N.W.; Jessop, T.C.; Wendor, P.A.; Dai, H. Nanotube molecular transporters: internalization of CNT-protein conjugates into mammalian cells. J. Am. Chem. Soc., 2004, 126, 6850-6851.
106. Ryman-Rasmussen, J. P.; Riviere, J.E.; Monteiro-Riviere, N.A. Penetration of Intact Skin by Quantum Dots with Diverse Physicochemical Properties. Toxicol. Sci., 2006, 1, 159-165.
107. Rouse, J.G.; Yang, J.; Ryman-Rasmussen, J.P.; Barron, A.R.; Monteiro-Riviere, N.A. Effects of Mechanical Flexion on the Penetration of Fullerene Amino Acid-Derivatized Peptide Nanoparticles through Skin. Nano Lett., 2007, 7, 155-160.
108. Isobe, H.; Tomita, N.; Jinno, S.; Okayama, H.; Nakamura, E. Synthesis and Transfection Capability of Multi-Functionalized Fullerene Polyamine. Chem. Lett., 2001, 12, 1214-1215.
109. Nakamura, E.; Isobe, H. Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience. Acc. Chem. Res., 2003, 36, 807-815.
110. Isobe, H.; Nakanishi, W.; Tomita, N.; Jinno, S.; Okayama, H.; Nakamura, E. Nonviral Gene Delivery by Tetraamino Fullerene. Mol. Pharm., 2006, 3, 124-134.
111. Zakharian, T.Y.; Seryshev, A.; Sitharaman, B.; Gilbert, B.E.; Knight, V.; Wilson, L.J. Fullerene Paclitaxel Chemotherapeutic: Synthesis, Characterization, and Study of Biological Activity in Tissue Culture. J. Am. Chem. Soc., 2005, 127, 12508-12509.
112. Lee, Y.T.; Chiang, L.Y.; Chen, W.J.; Hsu, H.C. Water-Soluble Hexasulfobutyl[60]fullerene Inhibit Low-Density Lipoprotein Oxidation in Aqueous and Lipophilic Phases. Proc. Soc. Exp. Biol. Med., 2000, 224, 69-75.
113. 60(OH)24 in doxorubicin induced hepatotoxicity in rats with mammary carcinomas. Biomaterials, 2008, 29, 3451-3460.
114. 60. Nature, 1991, 352, 787-788.
115. Iijima, S. Helical microtubules of graphitic carbon. Nature, 1991, 354, 56-57.
116. Ebbesen, T.W.; Ajayan, P.M. Large-scale synthesis of carbon nanotubes. Nature, 1992, 358, 220-221.
117. Goldshleger, N.F. Fullerenes and fullerne based materials in catalysis. Fullerene Sci. Technol., 2001, 9, 255-280.
118. 2] and its catalytic performance for cyclization of 1-heptene. Appl. Catal. A: Gen., 1998, 67, L1-L6.
119. Chen, Y.; Zhao, Y.; Cai, R.; Huang, Z.; Xiao, L. Anionic copolymerization of [60] fullerene with styrene initiated by sodium naphthalene, J. Polym. Sci. B Polym. Phys., 1998, 36, 2653-2663.
120. Halford, B. Fullerene for the face. Chem. Eng. News, 2006, 84, 47-48.
121. Zhou, Z.; Lenk, R.; Dellinger, A.; Macfarland, D.; Kumar, K.; Wilson, S.R.; Kepley, C.L. Fullerene nanomaterials potentiate hair growth. Nanomed: Nanotech. Bio. Med., 2009, 5, 202-207.
122. Foldvari, M.; Bagonluri, M. Carbon nanotubes as functional excipients for nanomedicine: I pharmaceutical properties. Nanomed. Nanotech. Biol. Med., 2009, 4, 173-182.
123. Ryan, J.J.; Bateman, H.R.; Stover, A.; Gomez, G.; Norton, S.K.; Zhao, W. Fullerene Nanomaterials Inhibit the Allergic Response. J. Immun., 2007, 179, 665-672.
124. Rezayat, S.M.; Boushehri, S.V.S.; Salmanian, B.; Omidvari, A.H.; Tarighat, S.; Esmaeili, S.; Sarkar, S.; Amirshahi, N.; Alyautdin, R.N.; Orlova, M.A.; Trushkov, I.V.; Buchachenko, A.L.; Liu, K.C.; Kuznetsov, D.A. The porphyrin-fullerene nanoparticles to promote the ATP overproduction in myocardium: 25Mg2{Thorn} -magnetic isotope effect. Eur. J. Med. Chem., 2009, 44, 1554-1569.
125. Ali, S.S.; Hardt, J.I.; Dugan, L.L. SOD Activity of carboxyfullerenes predicts their neuroprotective efficacy: a structure activity study. Nanomed. Nanotech. Bio. Med., 2008, 4, 283-294.
126. Foley, S.; Crowley, C.; Smaihi, M. Cellular localization of a water soluble fullerene derivative. Biochem. Biophys. Res. Commun., 2002, 294, 116-119.
127. Youle, R.J.; Karbowski, M. Opinion: mitochondrial fission in apoptosis. Nature Rev. Mol. Cell. Biol., 2005, 127, 12508-12509.
128. Marchesan, S.; Da Ros, T.; Spalluto, G.; Balzarini, J.; Prato, M. Anti HIV properties of cationic fullerene derivatives. Bioorg. Med. Chem. Lett., 2005, 15, 3615-3618.
129. 60/PVP) prevents the disturbance of long-term memory consolidation induced by cycloheximide. Fullerenes Nanotubes Carbon Nanostruct., 2004, 12, 443-446.
130. 60. Science, 1991, 254, 1183-1185.
131. Sayes, C.M.; Fortner, J.D.; Guo, W. The differential cytotoxicity of water soluble fullerenes. Nano Lett., 2004, 4, 1881-1887.
132. 60 cytotoxicity is due to lipid peroxidation. Biomaterials, 2005, 27, 7587-7595.
133. Sayes, C.M.; Liang, F., Hudson, J.L.; Mendez, J.; Guo, W.H.; Beach, J.M.; Moore, V.C.; Doyle, D.; West, J.L.; Billups, W.E.; Ausman, K.D.; Colvin, V.L. Functionalization density dependence of SWNT cytotoxicity in vitro. Toxicol. Lett., 2006, 161, 135-142.
134. Mroz, P.; Pawlak, A.; Satti, M.; Lee, H.; Wharton, T.; Gali, H.; Sarna, T.; Hamblin, M.R. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic. Biol. Med., 2007, 43, 711-719.
135. Boutorine, A.S.; Takasugi, H.; Isobe, H.; Nakamura, E.; Helene, C. Fullerene-Oligonucleotide Conjugates: Photoinduced Sequence Specific DNA Cleavage. Angew. Chem. Int. Ed. Engl., 1994, 33, 2462-2465.
136. Bosi, S.; Da Ros, T.; Spalluto, G. Synthesis and Anti HIV properties of new water soluble bis-functionalized [60]fullerene derivatives. Bioorg. Med. Chem. Lett, 2003, 13, 4437-4440.
137. Brettreich, M.; Hirsch, A. A highly water soluble dendro[60]fullerene. Tetrahedron Lett., 1998, 39, 2731-2734.
138. Schuster, D.I.; Wilson, S.R.; Kirschner, A.N. Evaluation of the Anti-HIV potency of a water soluble dendrimeric fullerene. Proc. Electrochem. Soc., 2000, 9, 267-270.
139. Marcheson, S.; Da Ros, T.; Spalluto, G.; Balzarini, J.; Prato, M. Anti HIV properties of cationic fullerene derivatives. Bioorg. Med. Chem., 2005, 15, 3615-3618.
140. 60. J. Nanoparticle Res., 2003, 5, 561-566.
141. 16AMBP to mineralized bone. Bioorg. Med. Chem., 2002, 10, 1991-1997.
142. Kato, H.; Yashiro, A.; Mizuno, A.; Nishida, Y.; Kobayashi, K.; Shinohara, H. Syntheses and Biological Evaluations of α-D-Mannosyl[60]fullerenols. Bioorg. Med. Chem. Lett., 2001, 11, 2935-2939.
143. Kim, J.E.; Lee, M. Fullerene inhibits -amyloid peptide aggregation. Biochem. Biophys. Res. Commun., 2003, 303, 576-579.
144. 60 fulleropyrrolidines bearing biologically active xanthine. Bioog. Med. Chem. Lett., 2008, 18, 99-103.
145. Lee, Y.T.; Chiang, L.Y.; Chen, W.J.; Hsu, H.C. Water-Soluble Hexasulfobutyl[60]fullerene Inhibit Low-Density Lipoprotein Oxidation in Aqueous and Lipophilic Phases. Proc. Soc. Exp. Biol. Med., 2000, 224, 69-75.
146. Foley, S.; Crowley, C.; Smaihi, M. Cellular localization of a water soluble fullerene derivative. Biochem. Biophys. Res. Commun., 2002, 294, 116-119.